{"name":"Bellicum Pharmaceuticals","slug":"bellicum-pharmaceuticals","ticker":"","exchange":"","domain":"bellicum.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxONUcyZkZtLVFSSWFpdGhncGlEYXF3OVZNV0lrMzB0M1dKNlhQUHFuLXZfT1V4NGdMSnV0UC1VektMVFA0SV8wQmd1LWxFTDZlZ2FlWlVHY3hYdjlEbEtIM3ctX2NqbHdkaTBpYnUwODdVTjNPR0xjeTFjTnZZejhVMHVnQ3JRcEoyS3lOSUtlcFBhRGc?oc=5","date":"2025-11-06","type":"pipeline","source":"Insightace Analytic","summary":"Immuno-Oncology Cell Therapy Market Share, Size, Growth and Forecast to 2034 - Insightace Analytic","headline":"Immuno-Oncology Cell Therapy Market Share, Size, Growth and Forecast to 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1rRnQ1LXRZcGYtR0xBZlRTLVRCVWlzMWJfenB5bHNBRGFRa01Qa245dVA0aFVqNFlTRHU2M25vX09hdjJieXZnSTJ4aUJDTlhSakI1cWFWYTF5SVJqTWp3?oc=5","date":"2024-12-30","type":"trial","source":"nature.com","summary":"PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial - nature.com","headline":"PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate can","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxQOTFNRmFOVjV3QnVlYzU5Yzhab0FEdDNpb1BiSWl6em8yUGZ5eVNveWRuMlpvNEZZTF9fR001Qmw1dFpWMEtHS2xkQUU2MkZDdVFta3pSMXdSVXhwZkdtLUg4d0NOX1NLa3Z0M0NBZnJ2Z0JvTk5kd3QzdU45N3Vqem1zX0xlSFpQQ2lBRXdFZ20xQ0NkclVRSG9odTBULTd2WVBXbEZRdkY5VHVrcWtjVXc4WXZXRzBIZzdGN2xaX2o0YWZaNUkyY0JvcWdDZ1NNZDBGVnJ5Mkc0M0k3azRiXzM0a0JRYmdQNkRLRzJqZFE0QUFQcW5WdVNYTHZKb19CQUxncW5pbEl6S2QtUWNSQnVVWGdsUQ?oc=5","date":"2024-10-21","type":"regulatory","source":"globenewswire.com","summary":"Allogeneic Hematopoietic Stem Cell Transplant Market to - globenewswire.com","headline":"Allogeneic Hematopoietic Stem Cell Transplant Market to","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE5nN0UwZFN6SS00YWR3UUd6SkxjRHJTdjJqUi1XdmhLbS1CMmlkckFmWjFTRmhkQXRBWVBOdkpyVHowd1Zxem1QbVU5czBRLUNnTVZIMGFhVlRZa0pVY2ZJQlVhWEh2bGk1ZjBXNERFNEpveF94LWlz0gF8QVVfeXFMT0p4dzQ4bXFoMlhaLTBIMFJzVFhpS3FhQmpBX29fSThZZk9hT2hWSlZ2X2xJSDNsTjhZRXJ3bUF3Uk52NWhvUWlhbmVkRGdKTEJnSnJLdUdPY3V3R3FXMXNmbk1UM253d0k4TEN0X2lfb2VfbjJuYzJaZjFVNA?oc=5","date":"2024-08-18","type":"pipeline","source":"BioInformant","summary":"Is the CAR-T Cell Therapy Craze Driving Pharma Investment? - BioInformant","headline":"Is the CAR-T Cell Therapy Craze Driving Pharma Investment?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOdjJCdHVNX2IwRm9LOFlxcWFpUVpVUndwcXhRTTIza2F6cXNweVNCc2dGTXQ4cVJpLVFBX3h5cENRaExJNWliN29ONDhnUVNzd0hEZUdfaUdtYnhmVldzcHBfaWRvTnJudlBnX3dwM3pQclUyb0Y0Q1VwVklzRGhHWFBPLXBEU2Z3U1FsRlcxZEh0UWtGRGZuMWhjQlZKX1VVXzlpVjZycUFfeC1HVkFJ?oc=5","date":"2024-02-22","type":"deal","source":"UT MD Anderson","summary":"MD Anderson acquires inducible switch technologies for cell therapy - UT MD Anderson","headline":"MD Anderson acquires inducible switch technologies for cell therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNM2EweHR2YTVjNGtjeWhVYWNVYWNUNmIxVF9RYUU5TDVJcDVMSDVjQS1oSWJOV1pKOWlLNmR0ajFYV3ViNXdJNTNJLXktOWg3NExFLUNEVEJhWHZ3eER6dHIyS0xzR1R2a1Q1R0dQUGlPV3QxbU5nRkZCYklNcU5zVTl6bnlLYWxNYzNmeDYtNmRpUUxtVVBQdlV4QV9hWEtudHdnSUZMeVRFX0V1ZXFndm9fLUtSWDQ?oc=5","date":"2024-02-21","type":"regulatory","source":"TipRanks","summary":"Bellicum Pharmaceuticals Finalizes Sale and Approves Dissolution - TipRanks","headline":"Bellicum Pharmaceuticals Finalizes Sale and Approves Dissolution","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxNSHktT29jMU1aOS10TWVveVhDUmk0Zm1ZQWh4VUdtSFNwaHhSTk1TejJxaEtwOTFITm1XWnhaM2ZyTUdxTUhlN2dqYUVOQXpJaE5RYVFRUXVhZ19tYmhtMHp3M0Z4UGFQNkhwNTF6U1MwNFJJYUJsZjZrVlhCSVFGT0N1NTJJMWk2R3IzQVFON2hOcDZzclZwWm0yS1dVcVpTRjJLQk00VjJHUXg1NmhMYmo3MXRoaWJ2TVNjMEV5WTBEN3lQRzBNS08wRklpZW1GUXN1V2ZTeHd6ZGw2VTlpcWNlX3lIUnBzR24teDdlMlZ5ell3ZzJVZ0NQTWpkbjIzNzFJak1FZ2hXUzJhcnV3Tg?oc=5","date":"2023-07-11","type":"trial","source":"PR Newswire","summary":"Sickle Cell Disease Clinical Trial Pipeline Accelerates as 40+ Pharma Companies Rigorously Developing Drugs for the Market Entry - PR Newswire","headline":"Sickle Cell Disease Clinical Trial Pipeline Accelerates as 40+ Pharma Companies Rigorously Developing Drugs for the Mark","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-06-14","type":"pipeline","source":"Moffitt","summary":"16MB049 aAPC: Artificial Antigen-Presenting Cells expressing CD3, CD28 and a Heparin-Binding Domain for Producing CAR-Ts - Moffitt","headline":"16MB049 aAPC: Artificial Antigen-Presenting Cells expressing CD3, CD28 and a Heparin-Binding Domain for Producing CAR-Ts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE5NSmZhdmdhcWI1eXFDSDdfN285dmtDSUJWS2tNZEhvWnE4ckZMRFIwNEpoaHNobXBUUUMyRjVpcWJQa0QwbHFRRmpHdktmblpzd2VpN3ZoYUUwdV9hT29PWFFiUG1iT2t5QmVZcEZVUQ?oc=5","date":"2021-10-11","type":"pipeline","source":"Labiotech.eu","summary":"A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology - Labiotech.eu","headline":"A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOWlZ0bVE2ZWpZS2J0MmRwaWFoRU81b3BVbmhmNmhCZ3VsODRzLW9GOC1aajZ6aW9odUM2NDhqOVlCYVpHeTdiNllBM1BGZDh1X0FSUGRndDVpa1Itc0phQUxFVV9iWXlTMTNzd0pWbFdKM1pRek9QdFZXTlhtaFEwTHduUzEyamdvWHBKNFZvVnhVcUZvNzBqM29iVkNwLUpIRXRmVS1pTkRpcmRONUtWaFJBdkZuZ0Fw?oc=5","date":"2020-10-30","type":"trial","source":"Fierce Biotech","summary":"Bellicum shares nose-dive on poor CAR-T data, program pause—company axes 79% of staffers - Fierce Biotech","headline":"Bellicum shares nose-dive on poor CAR-T data, program pause—company axes 79% of staffers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQTlZ5Q0h1bV9fWG54OTVnSjBGdTBSaUZqREFLb29fODNiWnU1TDlOdTd5YUFRTjBIR3ZYR2tHeUxkRjkxQlBQcFRXU3k1TnIxRkNqVmJzV2ZLOTN1VDZiUGNuX29xZHpSZDI4X09qc3pZUlhwNU1hVzZhMFRjN2toYl9oRl9nU01oQXMzU2UzNDF5RkpZQTU2UTRSbmRzMDVKVHcwUQ?oc=5","date":"2017-07-27","type":"pipeline","source":"BioPharma Dive","summary":"Novartis taps Cryoport for CAR-T logistics support - BioPharma Dive","headline":"Novartis taps Cryoport for CAR-T logistics support","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQUVFwZlF4SUd6UFhYcklyajZRQ3JvQWM5Unp0ZDlzdFBVMnlZbnlCWkkyRjJxeEhkTDFyZDl3ejBKcGlXZ0NpVDlFOVoxcC01OW5ZQTkweG04M3JHUTZwT0lUV1JJVXA5UGx1MDZLR0M4d01XVmU4R2tXMjExZXFrb0dPOWxWTVUxV05feGhPYm82TlpwRkE?oc=5","date":"2017-01-31","type":"pipeline","source":"Fierce Biotech","summary":"Genentech oncology head jumps ship to Bellicum as CEO - Fierce Biotech","headline":"Genentech oncology head jumps ship to Bellicum as CEO","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}